Chen, R.; Pagano, I.; Sun, Y.; Murakami, K.; Goodison, S.; Vairavan, R.; Tahsin, M.; Black, P.C.; Rosser, C.J.; Furuya, H.
A Diagnostic Gene Expression Signature for Bladder Cancer Can Stratify Cases into Prescribed Molecular Subtypes and Predict Outcome. Diagnostics 2022, 12, 1801.
https://doi.org/10.3390/diagnostics12081801
AMA Style
Chen R, Pagano I, Sun Y, Murakami K, Goodison S, Vairavan R, Tahsin M, Black PC, Rosser CJ, Furuya H.
A Diagnostic Gene Expression Signature for Bladder Cancer Can Stratify Cases into Prescribed Molecular Subtypes and Predict Outcome. Diagnostics. 2022; 12(8):1801.
https://doi.org/10.3390/diagnostics12081801
Chicago/Turabian Style
Chen, Runpu, Ian Pagano, Yijun Sun, Kaoru Murakami, Steve Goodison, Ramanathan Vairavan, Malak Tahsin, Peter C. Black, Charles J. Rosser, and Hideki Furuya.
2022. "A Diagnostic Gene Expression Signature for Bladder Cancer Can Stratify Cases into Prescribed Molecular Subtypes and Predict Outcome" Diagnostics 12, no. 8: 1801.
https://doi.org/10.3390/diagnostics12081801
APA Style
Chen, R., Pagano, I., Sun, Y., Murakami, K., Goodison, S., Vairavan, R., Tahsin, M., Black, P. C., Rosser, C. J., & Furuya, H.
(2022). A Diagnostic Gene Expression Signature for Bladder Cancer Can Stratify Cases into Prescribed Molecular Subtypes and Predict Outcome. Diagnostics, 12(8), 1801.
https://doi.org/10.3390/diagnostics12081801